APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parenteral Nutrition Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Parenteral Nutrition Solutions Market Outlook and Growth Opportunities 2026

20 December 2025204 pages

Choose your research edition.

Industry ResearchParenteral Nutrition Solutions Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral Nutrition Solutions Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Parenteral Nutrition Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral Nutrition Solutions Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral Nutrition Solutions Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Parenteral Nutrition Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Parenteral Nutrition Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Parenteral Nutrition Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Parenteral Nutrition Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Parenteral Nutrition Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Parenteral Nutrition Solutions market include Teva Pharmaceutical Industries, Pfizer (Hospira), Fresenius, B. Braun, Baxter International Inc., PSI Ltd, Pisa, Patheon and Ozon Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Parenteral Nutrition Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Parenteral Nutrition Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Parenteral Nutrition Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Parenteral Nutrition Solutions market.

Parenteral Nutrition Solutions Segment by Company

Teva Pharmaceutical Industries

Pfizer (Hospira)

Fresenius

B. Braun

Baxter International Inc.

PSI Ltd

Pisa

Patheon

Ozon Pharmaceuticals

Ostuka Pharmaceutical

Kelun Pharma

Huaren

CR Double-Crane

Cook Pharmica

BML Parenteral Drugs

Beximco Pharma

BAG Healthcare

Aspen Holdings

Albert David

Parenteral Nutrition Solutions Segment by Type

Large Volume Parenteral (LVP)

Small Volume Parenteral (SVP)

Parenteral Nutrition Solutions Segment by Application

Basic Infusion

Nutritious Infusion

Therapeutic Infusion

Parenteral Nutrition Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Parenteral Nutrition Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Parenteral Nutrition Solutions key companies, revenue, market share, and recent developments.

3. To split the Parenteral Nutrition Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Parenteral Nutrition Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Parenteral Nutrition Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Parenteral Nutrition Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Nutrition Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral Nutrition Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Nutrition Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Parenteral Nutrition Solutions industry.

Chapter 3: Detailed analysis of Parenteral Nutrition Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Parenteral Nutrition Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Parenteral Nutrition Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Parenteral Nutrition Solutions Industry Trends Table 2. Parenteral Nutrition Solutions Industry Drivers Table 3. Parenteral Nutrition Solutions Industry Opportunities and Challenges Table 4. Parenteral Nutrition Solutions Industry Restraints Table 5. Global Parenteral Nutrition Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Parenteral Nutrition Solutions Revenue Share by Company (2021-2026) Table 7. Global Parenteral Nutrition Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Parenteral Nutrition Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Parenteral Nutrition Solutions Company, Product Type & Application Table 10. Global Parenteral Nutrition Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Parenteral Nutrition Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Large Volume Parenteral (LVP) Table 15. Significant Companies of Small Volume Parenteral (SVP) Table 16. Global Parenteral Nutrition Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Parenteral Nutrition Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Parenteral Nutrition Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Parenteral Nutrition Solutions Sales Value Share by Type (2021-2026) Table 20. Global Parenteral Nutrition Solutions Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Basic Infusion Table 22. Significant Companies of Nutritious Infusion Table 23. Significant Companies of Therapeutic Infusion Table 24. Global Parenteral Nutrition Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Parenteral Nutrition Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Parenteral Nutrition Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Parenteral Nutrition Solutions Sales Value Share by Application (2021-2026) Table 28. Global Parenteral Nutrition Solutions Sales Value Share by Application (2027-2032) Table 29. Global Parenteral Nutrition Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Parenteral Nutrition Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Parenteral Nutrition Solutions Sales Value Share by Region (2021-2026) Table 32. Global Parenteral Nutrition Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Parenteral Nutrition Solutions Sales Value Share by Region (2027-2032) Table 34. Global Parenteral Nutrition Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Parenteral Nutrition Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Parenteral Nutrition Solutions Sales Value Market Share by Country (2021-2026) Table 37. Global Parenteral Nutrition Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Parenteral Nutrition Solutions Sales Value Market Share by Country (2027-2032) Table 39. Teva Pharmaceutical Industries Company Information Table 40. Teva Pharmaceutical Industries Business Overview Table 41. Teva Pharmaceutical Industries Parenteral Nutrition Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Teva Pharmaceutical Industries Parenteral Nutrition Solutions Product Portfolio Table 43. Teva Pharmaceutical Industries Recent Development Table 44. Pfizer (Hospira) Company Information Table 45. Pfizer (Hospira) Business Overview Table 46. Pfizer (Hospira) Parenteral Nutrition Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Pfizer (Hospira) Parenteral Nutrition Solutions Product Portfolio Table 48. Pfizer (Hospira) Recent Development Table 49. Fresenius Company Information Table 50. Fresenius Business Overview Table 51. Fresenius Parenteral Nutrition Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Fresenius Parenteral Nutrition Solutions Product Portfolio Table 53. Fresenius Recent Development Table 54. B. Braun Company Information Table 55. B. Braun Business Overview Table 56. B. Braun Parenteral Nutrition Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. B. Braun Parenteral Nutrition Solutions Product Portfolio Table 58. B. Braun Recent Development Table 59. Baxter International Inc. Company Information Table 60. Baxter International Inc. Business Overview Table 61. Baxter International Inc. Parenteral Nutrition Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Baxter International Inc. Parenteral Nutrition Solutions Product Portfolio Table 63. Baxter International Inc. Recent Development Table 64. PSI Ltd Company Information Table 65. PSI Ltd Business Overview Table 66. PSI Ltd Parenteral Nutrition Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. PSI Ltd Parenteral Nutrition Solutions Product Portfolio Table 68. PSI Ltd Recent Development Table 69. Pisa Company Information Table 70. Pisa Business Overview Table 71. Pisa Parenteral Nutrition Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pisa Parenteral Nutrition Solutions Product Portfolio Table 73. Pisa Recent Development Table 74. Patheon Company Information Table 75. Patheon Business Overview Table 76. Patheon Parenteral Nutrition Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Patheon Parenteral Nutrition Solutions Product Portfolio Table 78. Patheon Recent Development Table 79. Ozon Pharmaceuticals Company Information Table 80. Ozon Pharmaceuticals Business Overview Table 81. Ozon Pharmaceuticals Parenteral Nutrition Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Ozon Pharmaceuticals Parenteral Nutrition Solutions Product Portfolio Table 83. Ozon Pharmaceuticals Recent Development Table 84. Ostuka Pharmaceutical Company Information Table 85. Ostuka Pharmaceutical Business Overview Table 86. Ostuka Pharmaceutical Parenteral Nutrition Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Ostuka Pharmaceutical Parenteral Nutrition Solutions Product Portfolio Table 88. Ostuka Pharmaceutical Recent Development Table 89. Kelun Pharma Company Information Table 90. Kelun Pharma Business Overview Table 91. Kelun Pharma Parenteral Nutrition Solutions Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Kelun Pharma Parenteral Nutrition Solutions Product Portfolio Table 93. Kelun Pharma Recent Development Table 94. Huaren Company Information Table 95. Huaren Business Overview Table 96. Huaren Parenteral Nutrition Solutions Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Huaren Parenteral Nutrition Solutions Product Portfolio Table 98. Huaren Recent Development Table 99. CR Double-Crane Company Information Table 100. CR Double-Crane Business Overview Table 101. CR Double-Crane Parenteral Nutrition Solutions Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. CR Double-Crane Parenteral Nutrition Solutions Product Portfolio Table 103. CR Double-Crane Recent Development Table 104. Cook Pharmica Company Information Table 105. Cook Pharmica Business Overview Table 106. Cook Pharmica Parenteral Nutrition Solutions Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Cook Pharmica Parenteral Nutrition Solutions Product Portfolio Table 108. Cook Pharmica Recent Development Table 109. BML Parenteral Drugs Company Information Table 110. BML Parenteral Drugs Business Overview Table 111. BML Parenteral Drugs Parenteral Nutrition Solutions Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. BML Parenteral Drugs Parenteral Nutrition Solutions Product Portfolio Table 113. BML Parenteral Drugs Recent Development Table 114. Beximco Pharma Company Information Table 115. Beximco Pharma Business Overview Table 116. Beximco Pharma Parenteral Nutrition Solutions Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Beximco Pharma Parenteral Nutrition Solutions Product Portfolio Table 118. Beximco Pharma Recent Development Table 119. BAG Healthcare Company Information Table 120. BAG Healthcare Business Overview Table 121. BAG Healthcare Parenteral Nutrition Solutions Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. BAG Healthcare Parenteral Nutrition Solutions Product Portfolio Table 123. BAG Healthcare Recent Development Table 124. Aspen Holdings Company Information Table 125. Aspen Holdings Business Overview Table 126. Aspen Holdings Parenteral Nutrition Solutions Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Aspen Holdings Parenteral Nutrition Solutions Product Portfolio Table 128. Aspen Holdings Recent Development Table 129. Albert David Company Information Table 130. Albert David Business Overview Table 131. Albert David Parenteral Nutrition Solutions Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Albert David Parenteral Nutrition Solutions Product Portfolio Table 133. Albert David Recent Development Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Parenteral Nutrition Solutions Product Image Figure 2. Global Parenteral Nutrition Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral Nutrition Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Parenteral Nutrition Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Large Volume Parenteral (LVP) Image Figure 8. Small Volume Parenteral (SVP) Image Figure 9. Global Parenteral Nutrition Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Parenteral Nutrition Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Parenteral Nutrition Solutions Sales Value Share by Type (2021-2032) Figure 12. Basic Infusion Image Figure 13. Nutritious Infusion Image Figure 14. Therapeutic Infusion Image Figure 15. Global Parenteral Nutrition Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Parenteral Nutrition Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Parenteral Nutrition Solutions Sales Value Share by Application (2021-2032) Figure 18. Global Parenteral Nutrition Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Parenteral Nutrition Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Parenteral Nutrition Solutions Sales Value (2021-2032) & (US$ Million) Figure 21. North America Parenteral Nutrition Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Parenteral Nutrition Solutions Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Parenteral Nutrition Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Parenteral Nutrition Solutions Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Parenteral Nutrition Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Parenteral Nutrition Solutions Sales Value (2021-2032) & (US$ Million) Figure 27. South America Parenteral Nutrition Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Parenteral Nutrition Solutions Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Parenteral Nutrition Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Large Volume Parenteral (LVP)
  • Small Volume Parenteral (SVP)
Applications
  • Basic Infusion
  • Nutritious Infusion
  • Therapeutic Infusion
Companies covered
  • Teva Pharmaceutical Industries
  • Pfizer (Hospira)
  • Fresenius
  • B. Braun
  • Baxter International Inc.
  • PSI Ltd
  • Pisa
  • Patheon
  • Ozon Pharmaceuticals
  • Ostuka Pharmaceutical
  • Kelun Pharma
  • Huaren
  • CR Double-Crane
  • Cook Pharmica
  • BML Parenteral Drugs
  • Beximco Pharma
  • BAG Healthcare
  • Aspen Holdings
  • Albert David

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Parenteral Nutrition Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Parenteral Nutrition Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Parenteral Nutrition Solutions Market Dynamics
  1. 2.1 Parenteral Nutrition Solutions Industry Trends
  2. 2.2 Parenteral Nutrition Solutions Industry Drivers
  3. 2.3 Parenteral Nutrition Solutions Industry Opportunities and Challenges
  4. 2.4 Parenteral Nutrition Solutions Industry Restraints
3 Parenteral Nutrition Solutions Market by Company
  1. 3.1 Global Parenteral Nutrition Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Parenteral Nutrition Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Parenteral Nutrition Solutions Company Ranking (2024-2026)
  4. 3.4 Global Parenteral Nutrition Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Parenteral Nutrition Solutions Company Product Type and Application
  6. 3.6 Global Parenteral Nutrition Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Parenteral Nutrition Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Parenteral Nutrition Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Parenteral Nutrition Solutions Market by Type
  1. 4.1 Parenteral Nutrition Solutions Type Introduction
  2. 4.1.1 Large Volume Parenteral (LVP)
  3. 4.1.2 Small Volume Parenteral (SVP)
  4. 4.2 Global Parenteral Nutrition Solutions Sales Value by Type
  5. 4.2.1 Global Parenteral Nutrition Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Parenteral Nutrition Solutions Sales Value by Type (2021-2032)
  7. 4.2.3 Global Parenteral Nutrition Solutions Sales Value Share by Type (2021-2032)
5 Parenteral Nutrition Solutions Market by Application
  1. 5.1 Parenteral Nutrition Solutions Application Introduction
  2. 5.1.1 Basic Infusion
  3. 5.1.2 Nutritious Infusion
  4. 5.1.3 Therapeutic Infusion
  5. 5.2 Global Parenteral Nutrition Solutions Sales Value by Application
  6. 5.2.1 Global Parenteral Nutrition Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Parenteral Nutrition Solutions Sales Value by Application (2021-2032)
  8. 5.2.3 Global Parenteral Nutrition Solutions Sales Value Share by Application (2021-2032)
6 Parenteral Nutrition Solutions Regional Value Analysis
  1. 6.1 Global Parenteral Nutrition Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Parenteral Nutrition Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Parenteral Nutrition Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Parenteral Nutrition Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Parenteral Nutrition Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Parenteral Nutrition Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Parenteral Nutrition Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Parenteral Nutrition Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Parenteral Nutrition Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Parenteral Nutrition Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Parenteral Nutrition Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Parenteral Nutrition Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Parenteral Nutrition Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Parenteral Nutrition Solutions Sales Value Share by Country, 2025 VS 2032
7 Parenteral Nutrition Solutions Country-level Value Analysis
  1. 7.1 Global Parenteral Nutrition Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Parenteral Nutrition Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Parenteral Nutrition Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Parenteral Nutrition Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Parenteral Nutrition Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Parenteral Nutrition Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Parenteral Nutrition Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Parenteral Nutrition Solutions Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Pfizer (Hospira)
  8. 8.2.1 Pfizer (Hospira) Company Information
  9. 8.2.2 Pfizer (Hospira) Business Overview
  10. 8.2.3 Pfizer (Hospira) Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer (Hospira) Parenteral Nutrition Solutions Product Portfolio
  12. 8.2.5 Pfizer (Hospira) Recent Developments
  13. 8.3 Fresenius
  14. 8.3.1 Fresenius Company Information
  15. 8.3.2 Fresenius Business Overview
  16. 8.3.3 Fresenius Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Parenteral Nutrition Solutions Product Portfolio
  18. 8.3.5 Fresenius Recent Developments
  19. 8.4 B. Braun
  20. 8.4.1 B. Braun Company Information
  21. 8.4.2 B. Braun Business Overview
  22. 8.4.3 B. Braun Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 B. Braun Parenteral Nutrition Solutions Product Portfolio
  24. 8.4.5 B. Braun Recent Developments
  25. 8.5 Baxter International Inc.
  26. 8.5.1 Baxter International Inc. Company Information
  27. 8.5.2 Baxter International Inc. Business Overview
  28. 8.5.3 Baxter International Inc. Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Baxter International Inc. Parenteral Nutrition Solutions Product Portfolio
  30. 8.5.5 Baxter International Inc. Recent Developments
  31. 8.6 PSI Ltd
  32. 8.6.1 PSI Ltd Company Information
  33. 8.6.2 PSI Ltd Business Overview
  34. 8.6.3 PSI Ltd Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PSI Ltd Parenteral Nutrition Solutions Product Portfolio
  36. 8.6.5 PSI Ltd Recent Developments
  37. 8.7 Pisa
  38. 8.7.1 Pisa Company Information
  39. 8.7.2 Pisa Business Overview
  40. 8.7.3 Pisa Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pisa Parenteral Nutrition Solutions Product Portfolio
  42. 8.7.5 Pisa Recent Developments
  43. 8.8 Patheon
  44. 8.8.1 Patheon Company Information
  45. 8.8.2 Patheon Business Overview
  46. 8.8.3 Patheon Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Patheon Parenteral Nutrition Solutions Product Portfolio
  48. 8.8.5 Patheon Recent Developments
  49. 8.9 Ozon Pharmaceuticals
  50. 8.9.1 Ozon Pharmaceuticals Company Information
  51. 8.9.2 Ozon Pharmaceuticals Business Overview
  52. 8.9.3 Ozon Pharmaceuticals Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ozon Pharmaceuticals Parenteral Nutrition Solutions Product Portfolio
  54. 8.9.5 Ozon Pharmaceuticals Recent Developments
  55. 8.10 Ostuka Pharmaceutical
  56. 8.10.1 Ostuka Pharmaceutical Company Information
  57. 8.10.2 Ostuka Pharmaceutical Business Overview
  58. 8.10.3 Ostuka Pharmaceutical Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ostuka Pharmaceutical Parenteral Nutrition Solutions Product Portfolio
  60. 8.10.5 Ostuka Pharmaceutical Recent Developments
  61. 8.11 Kelun Pharma
  62. 8.11.1 Kelun Pharma Company Information
  63. 8.11.2 Kelun Pharma Business Overview
  64. 8.11.3 Kelun Pharma Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kelun Pharma Parenteral Nutrition Solutions Product Portfolio
  66. 8.11.5 Kelun Pharma Recent Developments
  67. 8.12 Huaren
  68. 8.12.1 Huaren Company Information
  69. 8.12.2 Huaren Business Overview
  70. 8.12.3 Huaren Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Huaren Parenteral Nutrition Solutions Product Portfolio
  72. 8.12.5 Huaren Recent Developments
  73. 8.13 CR Double-Crane
  74. 8.13.1 CR Double-Crane Company Information
  75. 8.13.2 CR Double-Crane Business Overview
  76. 8.13.3 CR Double-Crane Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CR Double-Crane Parenteral Nutrition Solutions Product Portfolio
  78. 8.13.5 CR Double-Crane Recent Developments
  79. 8.14 Cook Pharmica
  80. 8.14.1 Cook Pharmica Company Information
  81. 8.14.2 Cook Pharmica Business Overview
  82. 8.14.3 Cook Pharmica Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cook Pharmica Parenteral Nutrition Solutions Product Portfolio
  84. 8.14.5 Cook Pharmica Recent Developments
  85. 8.15 BML Parenteral Drugs
  86. 8.15.1 BML Parenteral Drugs Company Information
  87. 8.15.2 BML Parenteral Drugs Business Overview
  88. 8.15.3 BML Parenteral Drugs Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BML Parenteral Drugs Parenteral Nutrition Solutions Product Portfolio
  90. 8.15.5 BML Parenteral Drugs Recent Developments
  91. 8.16 Beximco Pharma
  92. 8.16.1 Beximco Pharma Company Information
  93. 8.16.2 Beximco Pharma Business Overview
  94. 8.16.3 Beximco Pharma Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Beximco Pharma Parenteral Nutrition Solutions Product Portfolio
  96. 8.16.5 Beximco Pharma Recent Developments
  97. 8.17 BAG Healthcare
  98. 8.17.1 BAG Healthcare Company Information
  99. 8.17.2 BAG Healthcare Business Overview
  100. 8.17.3 BAG Healthcare Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BAG Healthcare Parenteral Nutrition Solutions Product Portfolio
  102. 8.17.5 BAG Healthcare Recent Developments
  103. 8.18 Aspen Holdings
  104. 8.18.1 Aspen Holdings Company Information
  105. 8.18.2 Aspen Holdings Business Overview
  106. 8.18.3 Aspen Holdings Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Aspen Holdings Parenteral Nutrition Solutions Product Portfolio
  108. 8.18.5 Aspen Holdings Recent Developments
  109. 8.19 Albert David
  110. 8.19.1 Albert David Company Information
  111. 8.19.2 Albert David Business Overview
  112. 8.19.3 Albert David Parenteral Nutrition Solutions Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Albert David Parenteral Nutrition Solutions Product Portfolio
  114. 8.19.5 Albert David Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst